Bodal Chemicals Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹863 Cr +79.8% YoYSee revenue, profit and what management said. You are viewing Q1 FY26.
BC

Bodal Chemicals Ltd

Q1 FY26Chemicals & Petrochemicals

Bodal Chemicals Q1 FY26 earnings call: Revenue & Margins

Q1 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹454Cr
+7.6% YoY
+0.7% QoQ
Net profit
₹10Cr
Turned profitable YoY
−28.6% QoQ
Margin
10%
+2 pp YoY
0 pp QoQ

Bodal Chemicals Ltd Q1 FY26 key numbers

Revenue
Expecting 12%-13% EBITDA margin leading to INR70-80 crores net profit and 7%-8% return on investment.

As stated in Bodal Chemicals Ltd's Q1 FY26 earnings call transcript · published 30 May 2026. Reported figures, not investment advice.

Price₹79
Market cap₹950 Cr
P/E13.8

The short version

Company targets to reach INR2,000-2,100 crores revenue in FY27, up from about INR1,900 crores currently. Company targets revenue of around INR1,900 crores for FY26, with a potential upside or downside of 5%.

From Bodal Chemicals Ltd's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

Moderate growth
  • Company targets to reach INR2,000-2,100 crores revenue in FY27, up from about INR1,900 crores currently.
  • Expecting 12%-13% EBITDA margin leading to INR70-80 crores net profit and 7%-8% return on investment.
  • Growth expected from ramp-up in benzene derivatives and TCCA business volumes in next 3-6 months.
  • Benzene derivatives currently at 20%-30% utilization, targeting 70%-80% utilization by Q3/Q4 FY26.
  • TCCA market share expected to improve post-import duty clarity, with production resuming as inventory reduces by Q3/Q4.
  • Focusing on consolidating existing businesses with limited capex for next 2-3 years, mainly small debottlenecking.

2 more points from Bodal Chemicals Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Bodal Chemicals Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

No capex planned
  • No major capex planned in the next couple of years; focus is on consolidating and optimizing the current setup.
  • Small debottlenecking or Brownfield expansions may happen but will be very limited in scale.
  • Strategic land sale of about 8 acres at Rajpura to a large chlorine consumer to develop pipeline chlorine buyers, not a real estate deal but a business collaboration.
  • The company has about 62 acres of surplus land for future expansions, ensuring capacity for growth over the next 10-15 years.

2 more points from Bodal Chemicals Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Bodal Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Some relevant insights include: - TCCA production was paused due to inventory build-up but is expected to resume with clarity in future demand, likely by Q3 or Q4 of FY26. - Benzene derivatives business is ramping up, with utilization expected to reach 70-80% by Q4 FY26, indicating growing orders.

2 more points from Bodal Chemicals Ltd's call on order book

Create a free account to keep reading this call

What the Q1 FY26 call signalled

1 of 4 strong

RevenueModerate growth
MarginMargins slightly up
CapexNo capex planned
FundraiseNo fundraise planned

Bodal Chemicals Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Bodal Chemicals Ltd Q1 FY26 results — key figures

Bodal Chemicals Ltd Q1 FY26 reported results vs Q1 FY25, ₹ crore
₹ CrQ1 FY26Q1 FY25YoYQ4 FY25QoQ
Revenue454422+7.6%451+0.7%
Operating profit (EBITDA)4834+41.2%47+2.1%
Operating margin10%8%+2 pp10%0 pp
Profit before tax13-1—12+8.3%
Net profit (PAT)10-1—14-28.6%
EPS (₹)0.76-0.09—1.15-33.9%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹863 Cr, net profit ₹81 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Balaji Amines (Q1 FY26)

    Q1FY26 consolidated revenue from operations: ₹367 crore, up 2% quarter-on-quarter from ₹361 crore in Q4FY25, but down 7% year-on-year from ₹393 crore in Q1FY25…

  • Linde India (Q1 FY26)

    Net Revenue for FY ended Mar’25 was INR 24,854 million, down 10.2% (–2,833 million) YoY from INR 27,687 million. Key concall takeaways from Linde India Ltd's…

  • Vidhi Specialty (Q1 FY26)

    87.9 Crores . Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q1 FY26 earnings call — and how it ranks against sector peers.

  • Chemcon Speciality Chemicals (Q1 FY26)

    Q1 FY26 revenue from operations: ₹53.5 Cr, up 18% YoY from ₹45.5 Cr in Q1 FY25 (Page 7 & 6). Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q1…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Bodal Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Bodal Chemicals Ltd Q1 FY26 results?

Company targets to reach INR2,000-2,100 crores revenue in FY27, up from about INR1,900 crores currently. Company targets revenue of around INR1,900 crores for FY26, with a potential upside or downside of 5%.

What is Bodal Chemicals Ltd share price analysis?

Bodal Chemicals Ltd currently shows a below-average growth signal. The stock trades at a P/E of 13.8 with a market cap of ₹950 Cr. Investors should review the full earnings analysis for detailed insights.

Is Bodal Chemicals Ltd planning capital expenditure?

No major capex planned in the next couple of years; focus is on consolidating and optimizing the current setup.

Keep Bodal Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.